(EU 08/2003, S. 296 ff.) Singer, P.; Wirth, M.: Omega-3-Fettsäuren marinen und pflanzlichen Ursprungs: Versuch einer Bilanz

Literatur:

1. Christensen, J.H.; Gustenhoff, P.; Ejlersen, P.; Jessen, T.; Korup, E.; Rasmussen, K.; Dyerberg, J.; Schmidt, E.B.: Omega-3 Fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias. Nutr. Res. 15 , S.1-8.

2. Sellmayer, A.; Witzgall, H.; Lorenz, R.L.; Weber, P.C.: Effects of dietary fish oil on ventricular premature complexes. Am. J. Cardiol. 76 (1995), S.974-977.

3. Singer, P.; Wirth, M.: Günstiger Einfluss von Omega-3-Fettsäuren auf Herzrhythmusstörungen. Ernährungs-Umschau 49 (2002), S.178-181.

4. Singer, P.; Wirth, M.: Fischöl vermindert Herzrhythmusstörungen – Bedeutung für die Reduktion von Reinfarkten und plötzlichem Herztod. Med. Welt 54 (2003), S.1-8.

5. Siscovick, D.S. et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated acids and the risk of primary cardiac arrest. JAMA 274 (1995); S.1363-1367.

6. Albert, C.M.; Hennekens, C.H.; O´Donnell, C.J.; Ajani, U.A.; Carey, V.J.; Willet, W.C.; Ruskin, J.N; Manson, J.E: Fish consumption and risk of sudden cardiac death. JAMA 279 (1998), S.23-28.

7. Albert, C.M.; Campos, H.; Stampfer, M.J.; Ridker, P.M; Manson, J.E.; Willet, W.C.; Ma, J.: Blood levels of long-chain omega-3 fatty acids and the risk of sudden death. New Engl. J. Med. 346 (2002), S.1113-1118.

8. Hu, F.B.; Bronner, L.; Willet, W.C.; Stampfer, M.J.; Rexrode, K.M.; Albert, C:M.; Hunter, D.; Manson, J.E.: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287 (2002), S.1815-1821.

9. GISSI-Prevenzione Investigators: Early protection against sudden death by omega-3 polyunsaturated fatty acids after myocardial infarction. Circulation 105 (2002), S.1897-1903.

10. de Lorgeril, M.; Renaud, S.; Mamelle, N.; Salen, O.; Martin, J.-L.; Monjaud, I.; Guidollet, J.; Touboul, P.; Delaye, J.: Dietary prevention of sudden cardiac death. Europ. Heart J. 23 (2002), S.277-285.

11. Leaf, A.: On the reanalysis of the GISSI-Prevenzione. Circulation 105 (2002), S.1874-1875.

12. Rupp, H.; Verboorn, C.-N.; Jäger, B.: Saving lives post-MI: Highly purified omega-3 PUFAs for the prevention of sudden death. J. Clin. Basic Cardiol. 5 (2002), S.209-214.

13. Siscovick, D.S. et al.: Dietary intake of long-chain omega-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am. J. Clin. Nutr. 71 (Suppl.) (2000), S.208 S- 212 S.

14. Daviglus, M.L.; Stamler, J.; Orencia, A.J.; Dyer, A.R.; Liu, K.; Greenland, P.; Walsh, M.K.; Morris, D.; Shekelle, R.B.: Fish consumption and the 30-year risk of fatal myocardial infarction. New Engl. J. Med. 336 (1997), S.1046-1053.

15. Kromhout, D.; Bosschieter, E.B.; de Lezenne Coulander, C.: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New Engl. J. Med. 312 (1985), S.1205-1209.

16. The Multiple Risk Factor Trial Research Group: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a prior hypothesis of the trial. JAMA 263 (1990), S.1795-1801.

17. Lown, B.; Wolf, M.: Approaches to sudden death from coronary heart disease. Circulation 44 (1971), S.130-142.

18. Burr, M.L. et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial. Lancet 2 (1989), S.757-761.

19. GISSI-Prevenzione Investigators: Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354 (1999), S.447-455.

20. Contacos, C.; Bartes, P.J.; Sullivan, D.R.: Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler. Throm. 13 (1993), S.1755-1762.

21. Nakamura, N. et al.: Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acid on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int. J. Clin. Lab. Res. 29 (1999), S.22-25.

22. Singer, P.: Fluvastatin und Fischöl wirken stärker auf kardiovaskuläre Risikofaktoren als Fluvastatin allein. Med. Welt 53 (2002), S.298-302.

23. Jouven, X.; Charles, M.-A.; Desnos, M.; Ducimetière, P.: Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104 (2001), S.756-761.

24. Abeywardena, M.Y.; McLennan, P.L.; Charnock, J.S.: Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production. Am. J. Physiol. 260 (1991), S. H379-H385.

25. Leaf, A.; Kang, J.X.: Dietary omega-3 fatty acids in the prevention of lethal cardiac arrhythmias. Curr. Opin. Lipidol. 8 (1997), S.4-6.

26. Leaf, A.; Kang, J.X.; Xiao, Y.-F.; Billman, G.E.: Omega-3 Fatty acids in the prevention of cardiac arrhythmias. Lipids 34 (1999), S.187-189.

27. Nair, S.S.D.; Leitch, J.W.; Falconer,J.; Gary,M.L.: Prevention of cardiac arrhythmias by dietary (n-3) polyunsaturated fatty acids and their mechanisms of action. J. Nutr. 127 (1997), S.383-393.

28. Krauss, R.M.; Eckel, R.H.; Howard, B. et al.: AHA Dietary Guidelines - Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association. Circulation 102 (2000), S.2284-2299.

29. American Heart Association, Scientific Sessions, Chicago 2002.

30. The Report of the British Nutrition Foundation´s Task Force. Unsaturated Fatty Acids - Nutritional and Physiological Significance. Chapman and Hall, London, 1992.

31. Simopoulos, A.P.: ISSFAL Round Table. The future of fatty acids in human nutrition: Health and policy implications. ISSFAL Newsletter 2 (1995), S.2-3.

32. Simopoulos,A.P.; Leaf, A.; Salem, N.: Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann. Nutr. Metab. 43 (1999), S. 127-130.

33. Bjerve, K.S.; Fischer, S.; Wammer, F.; Egeland, T.: alpha-Linolenic acid and long-chain omega-3 fatty acid supplementation in three patients with omega-3 fatty acid deficiency: effect on lymphocyte function, plasma and red cell lipids, and prostanoid formation. Am. J. Clin. Nutr. 49 (1989), S.290-300.

34. Bjerve, K.S.; Mostad, I.L.; Thoresen, L.: Alpha-linolenic acid deficiency in patients on long-term gastric-tube feeding: estimation of linolenic acid and long-chain unsaturated omega-3 fatty acid requirement in man. Am. J. Clin. Nutr. 45 (1987), S.66-77.

35. Bjerve, K.S.: Omega-3 Fatty acid deficiency in man. J. Intern. Med. 225 (Suppl. 1) (1989), S.171-175.

36. Bjerve, K.S.: Omega-3 Fatty acid deficiency in man: Pathogenetic mechanisms and dietary requirements. N-3 News 4 (1989), S.1-4.

37. Dolecek, T.A.: Dietary omega-3-fatty acids and mortality in the MRFIT. 2nd International Congress on Preventive Cardiology, Washington,D.C., 18-22 June 1989 (Abstract).

38. Bahri, D.; Gusko, M.; Hamm, M.; Kasper, H.; Klöhr, H.-U.; Neuberger, D.; Singer, P.: Bedeutung und empfehlenswerte Höhe der Zufuhr langkettiger Omega-3-Fettsäuren - Ein Konsensus-Statement des Arbeitskreises Omega-3. Ernährungs-Umschau 49 (2002), S.94-98.

39. Fisch-Informationszentrum (FIZ): Daten und Fakten, Ausgabe 2001.

40. Deutsche Gesellschaft für Ernährung (Hrsg.): Ernährungsbericht 2000. DGE, Frankfurt/M., 2000.

41. Singer, P.: Was sind, wie wirken Omega-3-Fettsäuren? Umschau-Zeitschriftenverlag, Frankfurt/M., 2000.

42. de Lorgeril, M.; Renaud, S.; Mamelle, N.; Salen, P.; Martin, J.-L.; Monjaud, I.; Guidollet, J.; Touboul, P.; Delaye,J.: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 34 (1994), S.1454-1459.

43. de Lorgeril, M.; Salen, P.; Martin, J.-L.; Monjaud, I.; Delaye, J.; Mamelle, N.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 99 (1999), S.779-785.

44. Leaf, A.: Dietary prevention of coronary heart disease - The Lyon Diet Heart Study. Circulation 99 (1999), S.733-735.

45. Gerster, H.: Can adults adequately convert alpha-linolenic acid (18: 3 n-3) to eicosapentaenoic acid (20: 5 n-3) and docosahexaenoic acid (22: 6 n-3)? Internat. J. Vit. Nutr. Res. 68 (1998), S.159-173.

46. McKeigue, A.: Diets for secondary prevention of coronary heart disease: can linolenic acid substitute for oily fish? Lancet 343 (1994), S.1445.

47. Kris-Etherton, P. et al.: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program / American Heart Association step I dietary pattern on cardiovascular disease. Circulation 103 (2001), S.1823-1825.

48. Hartman, J.S.: Alpha-linolenic acid: a preventive in secondary coronary events? Nutr. Rev. 53 (1995), S.194-197.

49. de Lorgeril, M.; Salen, P.: Fish and omega-3 fatty acids for the prevention and treatment of coronary heart disease: nutrition is not pharmacology. Amer. J. Med. 112 (2002), S.316-319.

50. Singh, R.B.; Niaz, M.A.; Sharma, N.J. et al.: Randomized, double blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiments of Infarct Survival. Cardiovasc. Drugs Ther. 11 (1997), S.485-491.

51. von Schacky, C.: Was schützt wirklich vorm Herzinfarkt? MMW Fortschr. Med. 144 (2002), S.37-39.

52. von Schacky, C.: The role of omega-3 fatty acids in cardiovascular disease. Curr. Atheroscler. Rep. 5 (2003), S.139-145.

53. Hu, F.B.; Stampfer, M.J.; Manson, J.E. et al.: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am. J. Clin. Nutr. 69 (1999), S.890-897.

54. Hu, F.B.; Stampfer, M.J.; Manson, J.E.; Rimm, E.; Colditz, G.A.; Rosner, B.A.; Hennekens, C.H.; Willett, W.C.: Dietary fat intake and the risk of coronary heart disease in women. New Engl. J. Med. 337 (1997), S.1491-1499.

55. Hu, F.B.; Stampfer, M.J.; Manson, J.E.; Ascherio, A.; Colditz, G.A.; Speizer, F.E.; Hennekens, C.H.; Willet, .C.: Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Amer. J. Clin. Nutr. 70 (1999), S.1001-1008.

56. Hu, F.B.; Rimm, E.B.; Stampfer, M.J.; Ascherio, A.; Spiegelman, D.; Willet, W.C.: Prospective study of major dietary patterns and risk of coronary heart disease in men. Amer. J. Clin. Nutr. 72 (2000), S.912-921.

57. Singer, P.; Jaeger, W.; Berger, I.; Barleben, H.; Wirth, M.; Richter-Heinrich, E.; Voigt, S.; Gödicke, W.: Effects of dietary oleic, linoleic and a -linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension. J. Human Hypertens. 4 (1990), S.227-233.

58. Cunnane, S.C.; Chen, Z.-Y.; Yang, J.; Liede, A.C.; Hamdeh, M.; Crawford, M.A.: alpha-Linolenic acid in humans: Direct functional role or dietary precursors? Nutrition 7 (1991), S.437-439.

59. Harris, W.S.: Omega-3 Fatty acids and serum lipoproteins: human studies. Amer. J. Clin. Nutr. 65 (1997), S.1645S-1654S.

60. Layne, K.S.; Goh, Y.K.; Jumpsen, J.A.; Ryan, E.A.; Chow, P.; Clandinin, M.T.: Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J. Nutr. 126 (1996), S.2130-2140.

61. Kelley, D.S.; Nelson, G.J.; Love, J.E.; Branch, L.B.; Taylor, P.C., Schmidt, P.C.; Mackey, B.E.; Jacono, J.M.: Dietary a -linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans. Lipids 28 (1993), S.533-537.

62. Seppänen-Laakso, T.; Laakso, I.; Vanhanen, H.; Kiviranta, K.; Hiltunen, R.: Phospholipid and total plasma fatty acid composition in subjects using no fish in their diet. Prostagland. Leukotrien. Essential Fatty Acids 57 (1997)., S.218.

63. Kestin, M.; Clifton, P.; Belling, G.B.; Nestel, P.J.: Omega-3 Fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Amer. J. Clin. Nutr. 51 (1990), S.1028-1034.

64. Singer, P.: alpha-Linolenic acids vs. long-chain omega-3 fatty acids in hypertension and hyperlipidemia. Nutrition 8 (1992), S.133-135.

65. Singer, P.; Wirth, M.; Richter-Heinrich, E.: Omega-3-Fettsäuren vermindern Blutdruck, Thromboxan B2 und Stressreaktionen bei essentieller Hypertonie. Ernährungs-Umschau 50 (2003), S.40-44.

66. Brenner, R.R.: The oxidative desaturation of unsaturated fatty acids in animals. Molec. & Cell. Biochem. 3 (1974), S.41-52.

67. Horrobin, D.F.: Loss of delta-6-desaturase activity as a key factor in aging. Med. Hypotheses 7 (1981), S.1211-1220.

68. Horrobin, D.F:; Manku, M.S.; Huang, Y.S.: Effects of essential fatty acids on prostaglandin biosynthesis. Biomed. Biochim. Acta 43 (1984), S.114-120.

69. Pawlowsky, R.J.; Hibbeln, J.R.; Novotny, J.A.; Salem, N.: Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid. Res. 42 (2001), S.1257-1265.

70. Adam, O.: Ernährungsphysiologische Untersuchungen mit Formuladiäten: Der Stoffwechsel mehrfach ungesättigter Fettsäuren und die Prostaglandinbiosynthese beim Menschen. Klin. Wochenschr. 63 (1985), S.731-739.

71. Adam, O.; Wofram, G.; Zöllner, N.: Vergleich der Wirkung von Linolensäure und Eicosapentaensäure auf die Prostaglandinbiosynthese und Thrombozytenfunktion beim Menschen. Klin. Wochenschr. 64 (1986), S.274-280.

72. Gerster, H.: The use of n-3 PUFAs (fish oil) in enteral nutrition. Internat. J. Vit. Nutr. Res. 65 (1995), S.3-20.

73. Singer, P.; Berger, I.; Wirth, M.; Gödicke, W.; Jaeger, W.; Voigt, S.: Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects. Prostaglandins Leukotr. Med. 24 (1986), S.173-193.

74. Singer, P.: Defective conversion of linoleic and a -linolenic acids to arachidonic and eicosapentaenoic acids in normal, hypertensive and hyperlipaemic subjects. Akt. Ernähr. 15 (1990), S.39-42.

75. Singer, P.; Wirth, M.; Berger, I.; Heinrich, B.; Gödicke, W.; Voigt ,S.; Taube, C.; Jaross, W.; Gehrisch, S.: Long-chain omega-3 fatty acids are the most effective polyunsaturated fatty acids for dietary prevention and treatment of cardiovascular risk factors. World Rev. Nutr. Diet. 69 (1992) ,S.74-112.

76. Harris, W.S.; Connor, W.E.; McMurry, M.P.: The comparative reduction of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oils. Metabolism 32 (1983), S.179-184.

77. Brenner, R.R.; Peluffo, R.O.: Regulation of unsaturated fatty acid biosynthesis. I.Effect of unsaturated fatty acids of 18 carbons on the microsomal desaturation of linoleic to g -linolenic acid. Biochim. Biophys. Acta 176 (1969), S.471-489.

78. Horrobin, D.F.: Essential fatty acids and the complications of diabetes mellitus. Wien. klin. Wschr. 101 (1989), S.289-293.

79. Cleland, L.G.; James, M.J.; Neumann, M.A.; D´Angelo, M.; Gibson, R.A.: Linoleate inhibits EPA incorporation from dietary fish-oil supplement in human subjects. Am. J. Clin. Nutr. 55 (1992), S.395-399.

80. Sanders, T.A.B.; Roshanai, F.: The influence of different types of omega-3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin. Sci. 64 (1983), S.91-99.

81. Sanders, T.A.B.; Hinds, A.; Pereira, C.C.: Influence of n-3 fatty acids on blood lipids in normal subjects. J. Intern. Med. 225 (Suppl.1) (1989), S.99-104.

82. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J.: Fish consumption, fish oil, omega-3-fatty acids, and cardiovascular disease. Circulation 106 (2002), S.2747-2769.

83. Li, D.; Sinclair, A.; Wilson, A.; Nakkote, S.; Kelly, F.; Abedin, L.; Mann, N.; Turner, A.: Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am. J. Clin. Nutr. 69 (1999), S.872-882.

84. Ezaki, O. et al.: Long-term effects of dietary a -linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects. J. Nutr. Sci. Vitaminol. 45 (1999), S.759-772.

85. Mest, H.J.; Beitz, J.; Heinroth, I.; Block, H.-U.; Förster, W.: The influence of linseed oil diet on fatty acid pattern in phospholipids and thromboxane formation in platelets in man. Klin. Wochenschr. 61 (1983), S.187-191.

86. Singer, P.; Wirth, M.; Berger, I.: Zur mangelnden Synthese von Arachidon- und Eicosapaentaensäure aus Linol- und alpha-Linolensäure in klinischen Experimenten. Akt. Ernähr. 11 (1986), S.203-207.

87. Adam, O.: Zufuhr, Stoffwechsel, Wirkung und Nebenwirkungen der Omega-3-Fettsäuren. Fat. Sci. Technol. 91 (1991), S.97-103.

88. Singer, P.; Wirth, M.; Kretschmer, H.: Niedrig und hoch dosierte Supplementierung von alpha-Linolensäure im intraindividuellen Vergleich. In Vorbereitung.

89. Dyerberg, J.; Bang, H.O.; Aagaard, O.: alpha-Linolenic acid and eicosapentaenoic acid. Lancet I (1980), S.199.

90. Tinoco, J.: Dietary requirements and functions of alpha-linolenic acids in animals. Progr. Lipid Res. 21 (1982), S.1-45.

91. Simopoulos, A.P.: Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins, Leukotrienes Essential Fatty Acids 60 (1999), S.421-429.

92. DGE, ÖGD, SGE, SVE: Referenzwerte für die Nährstoffzufuhr. Umschau-Braus, Frankfurt/M., 2000.

93. Kris-Etherton, P.M.; Taylor, D.S.; Yu-Poth, S.; Huth, P.; Moriarty, K.; Fishell, V.; Hargrove, R.L.; Zhao, G.; Etherton, T.D.: Polyunsaturated fatty acids in the food chain in the United States. Amer. J. Clin. Nutr. 71 (Suppl.) (2000), S.179S-188S.

94. Pedersen, A.; Baumstark, M.W.; Marckmann, P.; Gylling, H.; Sandström, B.: An olive oil-rich diet results in higher concentration of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets. J. Lipid. Res. 41 (2000), S.1901-1911.

95. Bierenbaum, M.L.; Reichstein, R.P.; Watkins, T.R.; Maginnis, W.P.; Geller, M.: Effects of canola oil on serum lipids in humans. J. Amer. Coll. Nutr. 10 (1991), S.228-233.

96. Valsta, L.M.; Salminen, I.; Aro, A.; Mutanen, M.: alpha -Linolenic acid in rapeseed oil partly compensates for the effect of fish restriction on plasma long-chain n-3 fatty acids. Europ. J. Clin. Nutr. 50 (1996), S.229-235.

97. Almario, R.U.; Vonhavaravat, V.; Wong, R.; Kasim-Karakas, S.E.: Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am. J. Clin. Nutr. 74 (2001), S.72-79.

98. Hunter, J.E.: n-3 fatty acids from vegetable oils. Am. J. Clin. Nutr. 51 (1990), S.809-814.

99. Metz, G.: Omega-3-Fettsäuren - eine Standortbestimmung zum Millennium. Forum Medizin, Stockdorf, 2000.

100. Hunold, G.: Nachhaltige Entwicklung der Hochseefischerei. Inf. Fischwirtsch. Fischereiforsch. 47 (2000), S.163-169.

101. Vierling, K.: Leere Meere trotz Aquakultur. Berliner Zeitung, 5.3.2003.

102. Steffens, W.: Effects of variation in essential fatty acids in fish feeds on nutritive value of freshwater fish for humans. Aquaculture 151 (1997), S.97-119.

103. Bohl, M.: Die Regenbogenforellen als "Weltbürger". Fischer & Teichwirt 12 (2002), S.459-461.

104. Hahn, A.; Ströhle, A.; Schmitt, B.; Watkinson, B.N.: Wirkstoffe funktioneller Lebensmittel in der Prävention der Arteriosklerose. Teil 1: Physiologische Grundlagen der Wirkung von Omega-3-Fettsäuren. Teil 2: Omega-3-Fettsäuren - Versorgungssituation und Zufuhrempfehlungen. Ernährungs-Umschau 49 (2002), S.172-177, S.223-226.

105. Kluthe,R. et al.: Das Rationalisierungschema 2000 des BDEM, der Deutschen Adipositas Gesellschaft, der DAEM, der DGE, der DGEM und des VDD. Aktuel. Ernähr. Med. 25 (2000), S.263-270.

106. Kang, Z.B.; Ge, Y.; Chen, Z.; Cluett-Brown, J.; Laposata, M.; Leaf, A.; Kang, J.X.: Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Proc. Natl. Acad. Sci. USA 98 (2001), S.4050-4054.

107. Ge, Y.; Chen, Z.; Kang, Z.B.; Cluett-Brown, J.; Laposata, M.; Kang, J.X.: Effects of adenoviral gene transfer of C.elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Res. 22 (2002), S.537-544.

108. Hills, M:J.; Murphy, D.J.: Biotechnolgy of oilseeds. Biotechnol. Genet. Eng. Rev. 9 (1991), S. 41-46.

109. Sommerville, C.R.: future prospects for genetic modification of the composition of edible oils from higher plants. Am. J. Clin. Nutr. 58 (Suppl.) (1993), s. 270S-275S.

110. Hu, F.B.; Manson, J.E.; Willett, W.C.: Types of dietary fat and risk of coronary heart disease: A critical review. J. Amer. Coll. Nutr. 20 (2001), S.5-19.

111. Wolfram, G.; Fremann, D.: Referenzwerte mit Gewähr - Richtwerte für die Fettzufuhr. Ernährungs-Umschau 48 (2001), S.274-283.

112. Gaßmann, B.: Allezeit sicher ist nichts. Ernährungs-Umschau 49 (2002), S.169.

113. Schmandtke, H.: Entwicklung und Nutzung von Hybridölen und Ölen transgener Pflanzen. Ernährungs-Umschau 48 (2001), S.153-154.

114. Europäische Kommission (Hrsg.): Nährstoff- und Energiezufuhr in der Europäischen Gemeinschaft. Bericht Wissenschaftlicher Lebensmittelausschuss (SCF), 31. Folge, Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaft, Luxemburg, 1994. EU08/03